London, UK,
24
November
2015
|
08:00
Europe/London

Amec Foster Wheeler to collect radiological data for Canadian Nuclear Laboratories

Summary

Proprietary technology, ORION ScanPlotSM, deployed to detect gamma radiation in Port Hope area of Southern Ontario, Canada

Amec Foster Wheeler announces today that it is using state-of-the art radiation survey equipment to support the clean-up of approximately 1.2 million cubic metres of historic low-level radioactive waste from various sites in Southern Ontario, Canada.

The company is deploying its advanced ORION ScanPlotSM overland radiation survey system to collect radiological data under a CAD$1.57m contract awarded by Canadian Nuclear Laboratories (CNL).

Simon Naylor, Group President Americas
The use of ORION ScanPlotSM allows us to produce data of Final Status Survey Quality, which is accepted by regulators.

Depending upon its configuration and the detection criteria, the ScanPlotSM technology can examine up to 20 acres of open land per day, making it the most cost-effective way of doing this work.
Simon Naylor, Group President Americas

ScanPlotSM combines highly sensitive gamma radiation detectors with survey-grade GPS receivers. The radiological data is processed by an on-board computer to produce spatial mapping used to indicate the locations of historic low-level radioactive waste.

In Port Hope, Amec Foster Wheeler personnel are surveying approximately 175 roads and other public rights of way. ScanPlotSM technology is being deployed on a road trailer towed behind an all-terrain utility vehicle and in push-cart and backpack versions, enabling technicians to obtain data on all types of terrain.

The work is part of the Port Hope Area Initiative, the Canadian federal government’s undertaking for the safe, long-term management of historic low-level radioactive waste – primarily soil contaminated with residue ore from former radium and uranium refining activities.

Notes to editors

Amec Foster Wheeler (www.amecfw.com) designs, delivers and maintains strategic and complex assets for its customers across the global energy and related sectors.

 

With pro-forma 2014 annualised scope revenues of £5.5 billion and over 40,000 people in more than 55 countries, the company operates across the whole of the oil and gas industry – from production through to refining, processing and distribution of derivative products – and in the mining, clean energy, power generation, pharma, environment and infrastructure markets.

 

Amec Foster Wheeler shares are publicly traded on the London Stock Exchange and its American Depositary Shares are traded on the New York Stock Exchange. Both trade under the ticker AMFW.

 

Canadian Nuclear Laboratories (CNL) is a world leader in nuclear science and technology offering unique capabilities and solutions across a wide range of industries. Actively involved with industry-driven research and development in nuclear, transportation, clean technology, energy, defence, security and life sciences, CNL provides solutions to keep these sectors competitive internationally. For more information on the complete range of services CNL please visit www.cnl.ca or contact communications@cnl.ca.

 

Forward-Looking Statements

This announcement contains statements which constitute “forward-looking statements”. Forward-looking statements include any statements related to the timing and success of contracts, and are generally identified by words such as “believe,” “expect,” “anticipate,” “intend,” “estimate,” “will,” “may,” “continue,” “should” and other similar expressions. Forward-looking statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of Amec Foster Wheeler, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking statements.

 

Amec Foster Wheeler does not undertake to update any of the forward-looking statements after this date to conform such statements to actual results, to reflect the occurrence of anticipated results or otherwise.